A randomized controlled trial to reduce sedentary time in rheumatoid arthritis: protocol and rationale of the Take a STAND for Health study
Ana Jessica Pinto,
Tiago Peçanha,
Kamila Meireles,
Fabiana Braga Benatti,
Karina Bonfiglioli,
Ana Lúcia de Sá Pinto,
Fernanda Rodrigues Lima,
Rosa Maria Rodrigues Pereira,
Maria Claudia Costa Irigoyen,
James Edward Turner,
John P. Kirwan,
Neville Owen,
David W. Dunstan,
Hamilton Roschel,
Bruno Gualano
Affiliations
Ana Jessica Pinto
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Tiago Peçanha
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Kamila Meireles
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Fabiana Braga Benatti
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Karina Bonfiglioli
Rheumatology Division, Faculdade de Medicina FMUSP, Universidade de São Paulo
Ana Lúcia de Sá Pinto
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Fernanda Rodrigues Lima
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Rosa Maria Rodrigues Pereira
Rheumatology Division, Faculdade de Medicina FMUSP, Universidade de São Paulo
Maria Claudia Costa Irigoyen
Heart Institute, Faculty of Medicine, University of Sao Paulo
James Edward Turner
Department for Health, University of Bath
John P. Kirwan
Pennington Biomedical Research Center
Neville Owen
Baker Heart and Diabetes Institute
David W. Dunstan
Baker Heart and Diabetes Institute
Hamilton Roschel
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Bruno Gualano
Applied Physiology and Nutrition Research Group; Laboratory of Assessment and Conditioning in Rheumatology; Hospital das Clínicas HCFMUSP, Faculdade de Medicina FMUSP, Universidade de Sao Paulo
Abstract Background Patients with rheumatoid arthritis spend most of their daily hours in sedentary behavior (sitting), a predisposing factor to poor health-related outcomes and all-cause mortality. Interventions focused on reducing sedentary time could be of novel therapeutic relevance. However, studies addressing this topic remain scarce. We aim to investigate the feasibility and efficacy of a newly developed intervention focused on reducing sedentary time, and potential clinical, physiological, metabolic and molecular effects in rheumatoid arthritis. Methods The Take a STAND for Health study is a 4-month, parallel-group, randomized controlled trial, in which postmenopausal patients with rheumatoid arthritis will set individually tailored, progressive goals to replace their sedentary time with standing and light-intensity activities. Patients will be recruited from the Clinical Hospital (School of Medicine, University of Sao Paulo) and will be assessed at baseline and after a 4-month follow up. Outcomes will include objectively measured sedentary behavior (primary outcome) and physical activity levels, clinical parameters, anthropometric parameters and body composition; aerobic fitness, muscle function, blood pressure, cardiovascular autonomic function, vascular function and structure, health-related quality of life, and food intake. Blood and muscle samples will be collected for assessing potential mechanisms, through targeted and non-targeted approaches. Discussion Findings will be of scientific and clinical relevance with the potential to inform new prescriptions focused on reducing sedentary behavior, a modifiable risk factor that thus far has been overlooked in patients with rheumatoid arthritis. Trial registration ClinicalTrials.gov, NCT03186924. Registered on 14 June 2017.